Is This Stock a Screaming Buy: Ultralife Corp. (NASDAQ:ULBI)

Equity Research firms currently have a positive stance on shares of Ultralife Corp. (NASDAQ:ULBI). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.00. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $3.25 on a short term basis.

At the time of writing, the stock was trading at $3.92. This represents a change from the opening price of -0.25%. In terms of performance, year to date, the stock is -39.16%. The monthly stock performance comes in at -4.61%. For the quarter, shares are performing at -18.13%. Weekly performance analysis shows the equity at -4.38%.

In taking a look at technical levels, shares are trading -6.99% away from the 50 day simple moving average and -19.70% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -48.49% away from it’s 52- week high and 5.09% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Ultralife Corp.’s RSI stands at 34.40. In looking at volatility levels, the shares saw weekly volatility of 1.96% and 2.49% over the past month.

Leave a Comment